Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Combining subjective and objective appraisals of cognitive dysfunction in patients with cancer: a deeper understanding of meaning and impact on suffering?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Needs assessment in patients surgically treated for head and neck cancer-a randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment-results from the Swedish national ANCA study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Improvement of pain management in a comprehensive cancer center: a comparison of two cross-sectional studies 8 years apart

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Identification of palliative care needs in hemodialysis patients: An update

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term opioid treatment and endocrine measures in patients with cancer-related pain: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Specialiseret palliativ indsats til børn og unge og deres familier

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Improvement of pain management in a comprehensive cancer center: a comparison of two cross-sectional studies 8 years apart

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Patients with advanced cancer often experience cognitive dysfunction, which may influence decision making, self-perception, and existential well-being. However, there is little evidence regarding this issue. This study analysed associations between objective neuropsychological measures and patients' self-report of cognitive dysfunction interfering with everyday life, general well-being, and sense of existential value.

METHODS: A mixed method study assessed 13 adult patients with advanced cancer with validated neuropsychological tests, which assessed sustained attention, psychomotor speed, memory/attention, mental flexibility, and a measure of global cognitive function. These were followed by semi-structured interviews focusing on subjective experiences of cognitive dysfunction. Agreement between subjective and objective measures were analysed by Cohen's Kappa (k). Thematic analysis explored associations with cognitive deficits.

RESULTS: Poor cognitive performance on the neuropsychological tests was observed regarding sustained attention (n = 8), psychomotor speed (n = 1), memory/attention (n = 2), mental flexibility (n = 9), and global cognitive function (n = 3). Almost all patients (n = 12) had complaints of cognitive dysfunction. However, the agreement between the two assessments was weak (k ≤ 0.264). Cognitive dysfunction challenged the patients with regard to practice everyday life including their existential values related to meaning of life and well-being. Adjustment of the sense of living according to one's existential values and changes of self-perception were also related positively and negatively to existential well-being.

CONCLUSION: Despite the weak agreement between objective and subjective measures of cognitive function, many of the patients reported experiences of cognitive dysfunction that had an impact on their daily life and existential well-being, adding to the suffering experienced.

OriginalsprogEngelsk
TidsskriftSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Vol/bind30
Udgave nummer4
Sider (fra-til)3603-3612
Antal sider10
ISSN0941-4355
DOI
StatusUdgivet - apr. 2022

Bibliografisk note

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

ID: 79825770